Drug intelligence / Profile preview

cantharidin

Development stage
Approved
Lead developer
Verrica Pharmaceuticals
Modality
Small Molecules
Administration
Topical
01

Overview

Cantharidin is a naturally occurring terpenoid vesicant produced by blister beetles. It is an odorless, colorless fatty substance used topically in dermatology. The primary FDA-approved indication for cantharidin is the treatment of molluscum contagiosum in adults and children 2 years of age and older. In Canada and other regions, it is also approved for common warts (verruca vulgaris), periungual warts, and as part of combination products for plantar warts[4][5][6]. Its mechanism of action in treating molluscum contagiosum remains unknown; however, it acts as a vesicant (blistering agent) that induces acantholysis by targeting desmosomal structures within the skin[2][6][8]. Historically known as "Spanish fly," cantharidin has been used both therapeutically and illicitly due to its potent biological effects.

Brand names
YcanthCantharone PlusCanthacurCanthacur PS
Other names
Spanish fly
02

Targets

PP1 (Protein phosphatase 1)PPP2CA (Serine/threonine-protein phosphatase PP1-alpha catalytic subunit)

Beyond the preview

Go deeper on cantharidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cantharidin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call